India SEBI Regulatory Enforcement Actions — May 16, 2026

Q4 revenue +162% YoY to Rs 313.73 Cr, EBITDA +105% to Rs 43.69 Cr and volume +131% YoY driven by CrudeChem integration and new 80,000 MTPA Midland facility

First positive FCF Rs 89 Cr in FY26, Transport ROIC 16.0% and express parcel volumes +40.2% YoY with adjusted Transport EBITDA Rs 561 Cr

ICRA Long Term rating upgraded to A+ (Positive) and Short Term to A1+ (Positive); NABL accreditation for third consecutive year

Capex as % of revenue reduced to 3.3% in FY26 while EBITDA margin reached 7.3%

FY26 revenue +45% to Rs 772.23 Cr with PAT +14% to Rs 125.01 Cr and promoter warrant conversion of Rs 17.30 Cr

Board approved 5-year independent director appointment of ex-Global CFO of Tata Communications with zero related-party relationships

Total capacity expanded to 2,00,000 MTPA across five plants including Brookshire USA facility

Statutory auditors issued unmodified opinion on FY26 results with no material misstatements

BSE fine of Rs 4,60,000 + GST for Regulation 17(1) board composition non-compliance in Q2 FY26; waiver application submitted but outcome pending

Medium-risk SEBI enforcement action with 7/10 materiality; limited operational disclosure increases uncertainty

Cash & cash equivalents declined to Rs 4,555 Cr at Mar'26 from Rs 5,493 Cr YoY after M&A spend

New initiatives Adjusted EBITDA loss widened to Rs 76 Cr in FY26 while Supply Chain Services posted Rs 4 Cr loss at 0% margin

Regulatory action flagged at medium risk 7/10 despite strong results; potential for further SEBI scrutiny on compliance

Board meeting held with medium risk 7/10 but no forward-looking guidance or period comparison data released

Non-compliance persisted through Sep 2025 quarter and remains under Ministry of Chemicals control, limiting remediation speed

2,00,000 MTPA total capacity with 80,000 MTPA Permian Basin facility now at optimal utilization offers volume growth runway into FY27

First positive FCF of Rs 89 Cr and 16% Transport ROIC signal operating leverage inflection; watch for margin expansion in new initiatives

ICRA A+ (Positive) upgrade plus promoter warrant conversion of Rs 35.68 Cr total subscription strengthens balance sheet for further M&A

Express parcel volumes +40.2% YoY and PTL tonnage +17.4% YoY with EBITDA margin 7.3% position company for market share gains vs slower peers

CrudeChem Technologies 53.33% stake and Brookshire USA facility provide USD revenue exposure and geographic diversification

Appointment of seasoned ex-Microsoft India CFO Kabir Ahmed Shakir for 2026-2031 term enhances governance and financial oversight

Q4 EBITDA margin expansion to 13.9% (from FY26 17.4% but still +105% absolute) after facility ramp-up

3/10 filings involve SEBI fines or medium-risk actions (HOCL Rs 4.6L, KOURA, Fineotex) yet 2 companies posted >40% revenue growth and rating upgrades, indicating selective enforcement focused on governance rather than business conduct

Delhivery achieved 7.3% EBITDA margin with positive FCF while Fineotex delivered 105% EBITDA growth; aggregate data shows 2/2 growth companies reduced capex intensity (Delhivery 3.3%, Fineotex facility utilization optimized)

Delhivery cash fell Rs 938 Cr YoY post-M&A while Fineotex raised Rs 35.68 Cr via warrants; pattern suggests sector preference for inorganic growth funded by equity over debt

HOCL cited Ministry control as reason for 17(1) non-compliance; 426th board meeting on 15.05.2026 and waiver filing highlight ongoing public-sector compliance challenges across 2/10 filings

BSE waiver decision on Rs 4.6L fine expected post-426th board meeting; monitor for escalation or clearance [15.05.2026 onward]

Watch Q1 FY27 volume trends and new initiatives loss trajectory after FY26 positive FCF milestone; next results due Aug 2026

Monitor CrudeChem integration margins and US facility utilization post A+ rating upgrade; Q1 FY27 investor presentation expected

Follow SEBI enforcement resolution timeline given medium 7/10 risk and limited disclosure

Next board meeting updates required to assess capital allocation or regulatory stance post May 16 meeting

Track cash balance recovery after Rs 4,555 Cr level and any further M&A announcements

Promoter warrant exercise completion and any additional capital allocation announcements post Rs 17.30 Cr subscription